| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT00475137 | Bipolar II Disorder, Most Recent Episode Major Depressive | Drug: Lamotrigine|Drug: Lamotrigine | University of British Columbia | Phase 2 | 2007-12-01 | 2015-06-02 |
| NCT02513654 | Bipolar Disorder | Drug: Lamotrigine | GlaxoSmithKline | Phase 1 | 2015-09-01 | 2016-01-14 |
| NCT02303106 | Healthy | Drug: Lamotrigine | Per Damkier|Odense University Hospital | Phase 4 | 2014-11-01 | 2015-04-21 |
| NCT01131975 | Healthy | Drug: Lamotrigine | Dr. Reddy's Laboratories Limited | Phase 1 | 2003-01-01 | 2010-06-11 |
| NCT01131949 | Healthy | Drug: Lamotrigine | Dr. Reddy's Laboratories Limited | Phase 1 | 2003-01-01 | 2010-06-11 |
| NCT02064465 | Epilepsy | Drug: Lamotrigine Dispersible/Chewable tablet|Drug: Lamotrigine Compressed tablet | GlaxoSmithKline | Phase 1 | 2014-03-01 | 2017-01-25 |
| NCT01996293 | Bipolar Disorder | Drug: lamotrigine | Northwestern University | | 2013-09-01 | 2016-09-21 |
| NCT00176228 | Bipolar Disorder | Drug: Lamotrigine | University of Illinois at Chicago|GlaxoSmithKline | Phase 2 | 2004-02-01 | 2015-07-28 |
| NCT00621842 | Bipolar Disorder|Depression, Bipolar | Drug: Lamotrigine regular tablet formulation|Drug: Lamotrigine novel formulation | University Hospitals Cleveland Medical Center|GlaxoSmithKline | Phase 3 | 2008-01-01 | 2014-12-08 |
| NCT01995825 | Epilepsy | Drug: lamotrigine | University of Maryland|Food and Drug Administration (FDA) | Phase 4 | 2012-05-01 | 2015-03-12 |
| NCT00243152 | Facial Neuropathy | Drug: Lamotrigine | Pain and Analgesia Imaging and Neuroscience Group|GlaxoSmithKline | 2005-10-01 | 2012-11-29 |
| NCT00181844 | Bipolar Disorder|Mania | Drug: lamotrigine | Massachusetts General Hospital | Phase 4 | 2005-01-01 | 2012-03-09 |
| NCT02821338 | Healthy | Drug: Lamotrigine Extended Release | Food and Drug Administration (FDA)|Vince & Associates Clinical Research, Inc.|Algorithme Pharma Inc | Phase 4 | 2016-06-01 | 2017-02-27 |
| NCT01879423 | Epilepsy | Drug: Lamotrigine Dispersible/Chewable tablets 5mg*5|Drug: Lamotrigine Compressed tablet 25mg | GlaxoSmithKline | Phase 1 | 2013-04-01 | 2017-01-25 |
| NCT00789113 | Epilepsy|Seizures|Bipolar Disorder|Bipolar Depression | Drug: Extended Release Lamotrigine | University of Minnesota - Clinical and Translational Science Institute|GlaxoSmithKline | Phase 1|Phase 2 | 2008-11-01 | 2015-12-14 |
| NCT01513681 | Healthy | Drug: Lamotrigine|Drug: Lamictal | Dr. Reddy's Laboratories Limited | Phase 1 | 2002-11-01 | 2012-01-17 |
| NCT01513720 | Healthy | Drug: Lamotrigine|Drug: Lamictal | Dr. Reddy's Laboratories Limited | Phase 1 | 2002-12-01 | 2012-01-17 |
| NCT01042496 | Bipolar Depression | Drug: Lamotrigine|Procedure: 1H-MR | Mayo Clinic|National Institute of Mental Health (NIMH) | Phase 3 | 2009-12-01 | 2016-01-12 |
| NCT00896987 | Epilepsy | Drug: lamotrigine (Lamictal)|Drug: Carbamazepine (Tegretol) | Korean Epilepsy Society|GlaxoSmithKline | Phase 4 | 2006-05-01 | 2009-05-11 |
